Suppr超能文献

人结肠腺癌细胞系SW 620在无胸腺小鼠体内异种移植生长的生物学特性。

Biological properties of the human colonic adenocarcinoma cell line SW 620 grown as a xenograft in the athymic mouse.

作者信息

Stragand J J, Barlogie B, White R A, Drewinko B

出版信息

Cancer Res. 1981 Sep;41(9 Pt 1):3364-9.

PMID:7260902
Abstract

The biological and cell kinetic properties of the poorly differentiated human colonic adenocarcinoma cell line SW 620 grown as xenografts in BALB/c athymic mice are described. The SW 620 cells consistently produced tumors when inoculated i.v., i.p., and s.c. The lowest cell inoculum requirements were seen i.p. where 10(7) cells produced a 100% incidence. Intravenous inocula (10(5) to 10(8) cells) produced microscopic lung colonies within 30 days, becoming macroscopic nodules after 60 days. Subcutaneous tumors exhibited a marked Révész effect, using a thromboplastic brain extract which increased both tumor incidence and growth rate. All SW 620 xenografts presented a poorly differentiated morphology with extensive necrotic foci. No metastatic involvement was noted in any murine tissues. No demonstrable levels of carcinoembryonic antigen were present in the sera of animals bearing s.c. xenografts greater than 5.0 cu cm. Early SW 620 xenografts (0.3 to 0.6 cu cm) exhibited a characteristically human cell kinetic profile (Tc congruent to 34 to 43 hr; Ts congruent to 22 hr), with a growth fraction of 30.5% as measured by the primer-available DNA polymerase-index and a high cell loss factor (45%). Among late xenografts (1.1 to 1.6 cu cm), the kinetic events noted were an increase in the Tc, cell loss and, unexpectedly, an increase in the primer-available DNA polymerase index. A colony formation assay was established with the use of mechanical mincing plus collagenase (150 IU/ml; 37 degrees; 30 min), which produced a mean plating efficiency of 33.6 +/- 7.2% (S.E.) for s.c. xenografts (range, 14.6 to 51.0%). The SW 620 xenograft model possesses the biological and cell kinetic profile of many human colonic adenocarcinomas in situ. These properties, coupled with the capacity for large-scale xenograft production, should provide a clinically relevant model for the screening of potential antitumor agents and procedures.

摘要

本文描述了低分化人结肠腺癌细胞系SW 620在BALB/c裸鼠体内异种移植生长时的生物学和细胞动力学特性。SW 620细胞经静脉、腹腔和皮下接种后均能持续产生肿瘤。腹腔接种所需的细胞接种量最低,接种10⁷个细胞时肿瘤发生率达100%。静脉接种(10⁵至10⁸个细胞)在30天内产生显微镜下可见的肺集落,60天后形成肉眼可见的结节。皮下肿瘤使用促凝血脑提取物后呈现明显的雷维斯效应,肿瘤发生率和生长速率均增加。所有SW 620异种移植瘤均呈现低分化形态,伴有广泛坏死灶。在任何鼠组织中均未发现转移。皮下异种移植瘤体积大于5.0立方厘米的动物血清中未检测到可证实水平的癌胚抗原。早期SW 620异种移植瘤(0.3至0.6立方厘米)呈现典型的人类细胞动力学特征(Tc约为34至43小时;Ts约为22小时),通过引物可用DNA聚合酶指数测量生长分数为30.5%,细胞丢失率高(45%)。在晚期异种移植瘤(1.1至1.6立方厘米)中,观察到的动力学事件包括Tc增加、细胞丢失,以及出乎意料的引物可用DNA聚合酶指数增加。使用机械切碎加胶原酶(150 IU/ml;37℃;30分钟)建立了集落形成试验,皮下异种移植瘤的平均接种效率为33.6±7.2%(标准误)(范围为14.6至51.0%)。SW 620异种移植瘤模型具有许多原位人结肠腺癌的生物学和细胞动力学特征。这些特性,再加上大规模异种移植瘤生产的能力,应为筛选潜在抗肿瘤药物和程序提供一个临床相关模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验